Two Novartis leaders share their perspectives on digital health in 2020 – and the key trends to watch out for over the next 12 months.

Experts call for significant changes to facilitate the discovery of new treatments.

Novartis team perseveres to develop more personalized approach to breast cancer therapy.

Novartis is investing in a novel type of medicine to reduce the risk of heart disease.

Novartis investigators find genetic explanations for why some young patients relapse.

Combination of two compounds shows promise in the lab

Patrice Matchaba shares how a lifetime of experience helped shape an effort to address healthcare disparities.

Novartis data scientists are using super-resolution microscopy to see neurodegeneration the moment it starts.